Literature DB >> 30658224

Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.

Jaleel Mohammed1, Sean R Smith2, Linda Burns3, Grzegorz Basak4, Mahmoud Aljurf5, Bipin N Savani6, Helene Schoemans7, Zinaida Peric8, Naeem A Chaudhri9, Nnenna Chigbo10, Arun Alfred11, Hadeel Bakhsh12, Nina Salooja13, Amah Chris Chim14, Shahrukh K Hashmi15.   

Abstract

Hematopoietic stem cell transplantation (HSCT) patients can suffer from various musculoskeletal problems resulting in long-term functional incapacity. Physical therapy (PT), as a part of the healthcare team, has been historically advocated for regaining functional capacity and improving quality of life post-HSCT. Because of the nature of this condition and the burden of post-transplant complications, this patient group requires a unique approach toward their rehabilitation that takes into account their complex musculoskeletal presentation ranging from fascia, muscle, tendons, bones, and ligaments. However, to our knowledge there is no universal standardized PT protocol or pathway to help guide rehab specialists to achieve optimal gains for this patient group, and anecdotal evidence suggests that these patients do not always receive the PT care they require. Hence, in collaboration with the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation, the Survivorship Special Interest Group of the American Society of Blood and Marrow Transplantation, and the Quality of Life Committee of the Eastern Mediterranean Blood and Marrow Transplantation, herein the Physical Therapy Association for Graft Versus Host Disease provides a brief review on role of PT in mitigating musculoskeletal complications in HSCT patients and makes evidence-based recommendations for incorporation of PT into routine HSCT care.
Copyright © 2019 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic; Exercise; HSCT; Physical therapy

Mesh:

Year:  2019        PMID: 30658224     DOI: 10.1016/j.bbmt.2019.01.018

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.

Authors:  Rebecca L Olin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT).

Authors:  Teresa López-Fernández; Irene Sánchez Vadillo; Ana López de la Guía; Karem Humala Barbier
Journal:  Curr Treat Options Oncol       Date:  2021-04-30

Review 3.  Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT).

Authors:  Fiona Roberts; Helen Hobbs; Helen Jessop; Cristina Bozzolini; Joachim Burman; Raffaella Greco; Azza Ismail; Majid Kazmi; Kirill Kirgizov; Gianluigi Mancardi; Susan Mawson; Paolo A Muraro; Mathieu Puyade; Riccardo Saccardi; Barbara Withers; Bregje Verhoeven; Basil Sharrack; John A Snowden
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

4.  Screening supportive care needs, compliance with exercise program, quality of life, and anxiety level during the COVID-19 pandemic in individuals treated with hematopoietic stem cell transplantation.

Authors:  Vesile Yildiz Kabak; Songul Atasavun Uysal; Tulin Duger
Journal:  Support Care Cancer       Date:  2021-01-06       Impact factor: 3.359

5.  Using the MDASI-Adolescent for Early Symptom Identification and Mitigation of Symptom Impact on Daily Living in Adolescent and Young Adult Stem Cell Transplant Patients.

Authors:  Irtiza N Sheikh; Jeffrey Miller; Basirat Shoberu; Clark R Andersen; Jian Wang; Loretta A Williams; Kris M Mahadeo; Rhonda Robert
Journal:  Children (Basel)       Date:  2021-12-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.